drtarsh
@drtarsh
Followers
1K
Following
6K
Statuses
2K
MD FRCP MRCGP ICOS-Certified Cardio-Oncologist @RoyalBrompton/Primary Care Physician/@ProstateUKProfs Clinical Champion. #CardioOnc #JACCCardioOnc/Views my own
London, England
Joined April 2011
Who is a cardio-oncologist? Looking after the hearts of cancer patients before, during and long after cancer treatment.
4
12
68
Could CHIP be a new biomarker for #heartfailure after treatment for lymphoma with #HCT ? #CardioOnc #Oncology #medtwitter
CHIP was highly prevalent & assoc w risk for HF & nonrelapse mortality after #HCT. These findings highlight the role of #CHIP as a novel biomarker & potential target for intervention to improve outcomes after autologous HCT #JACCCardioOnc #CardioOnc #lymsm
0
0
7
RT @SaadMahmoodMD: Looking forward to hosting this @ICOSociety journal club on the CORE trial with @JustinSongMD incoming cardiology fellow…
0
2
0
RT @hmkyale: 🚨 NEW in @JACCJournals: Despite global initiatives, 2° prevention medication use in CVD stagnant or declining in most income-l…
0
15
0
RT @ProstateUKProfs: Prostate cancer is now the most common cancer in England. If you're a health professional looking to improve support…
0
1
0
Congratulations @avirupguha @nickolastab on the development of these much needed cancer specific CVD risk scores. #CardioOnc #CardioOncology #cancer #CVDrisk
CVD risk is up to 3x higher in cancer patients, but traditional risk scores fail to account for cancer-specific factors. @nickolastab helped us developed ML-driven, cancer-specific CVD risk scores that outperform conventional models. #CardioOnc #CancerCare #cardiosky
0
3
8
RT @Richardkcheng2: Join us for the ACC cardio-oncology meeting Feb 14-16, sold out in person but virtual option still available! Amazing s…
0
9
0
Delighted to interview the co-chair of the ESC cardio-oncology guidelines #DrAlexLyon about his career in #CardioOnc #cardiology #oncology #cancer Podcast Episode: JACC: CardioOncology Pulse - Cardio-Oncology Past, Present, and Future
4
13
122
RT @sdent_cardioonc: Important to consider comorbidities when treating HR+ HER2 - metastatic breast cancer. @ICOSociety @WilmotCancer …
0
9
0
@oncology_cardio @ICOSociety @escardio @AHP_PAKS @oncodaily @PennThalheimer @AnnaBorowiec5 @SverdlovAaron @DrRaulCordoba @Dr_Mike_Fradley @DrSFeldman @franckthuny @dineshpmcc1 Congratulations Sebastian!
0
1
1
Interesting ….
🫀 NLR, an inexpensive and easy #biomarker, improves risk stratification in patients with #Myocarditis. Read the full story at #JACCHF #whyMRI #CardioTwitter
@BromageDan @BiykemB @gbiondizoccai @AbbateAntonio @JACCJournals @DjawidHashemi @HanCardiomd
0
0
1
RT @TheLancet: Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomise…
0
26
0
RT @ICOSociety: #Mothers and #pregnant women face unique challenges when being treated for #cancer. If you are a mother currently undergoin…
0
3
0
RT @oncology_cardio: Webinar organised by Supportive Care Section of the Polish🇵🇱 Society of Clinical Oncology with President of @CancerCar…
0
1
0
Congratulations Sohaib!
Following a £13m award from the @The_MRC, total body PET allows unprecedented detailed imaging of the human body. A huge credit to the colossal effort and incredible team @KingsImaging @KingsCollegeLon @GSTTnhs to lead this forward so we can improve patient diagnosis and care.
0
0
1
Highly recommend becoming a member
Looking to kick off the new year on the right foot? Become a member of the world's leading #cardioonc society! Join #cardiooncologists from around the world in protecting patients' hearts, driving progress, and advancing your career. Sign up today:
0
1
4
RT @JACCJournals: Premenopausal #BreastCA survivors treated with aromatase inhibitors & ovarian suppression face a 2.2-fold higher risk of…
0
7
0